Clinical Trial Update: Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Compound Kushen Injection for advanced colorectal cancer is currently recruiting, with the study seeking potential survival benefits.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Compound Kushen Injection (Kushen (Sophora flavescens) extract injection containing matrine/oxymatrine)

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Advanced Colorectal Carcinoma | Phase 4 | Status: RECRUITING